Friday 23rd October 2020 Missed our free GatewayC webinar on Acute Leukaemia? Watch our recording here. In this webinar GatewayC met Dr Amit Patel, a Consultant in Cellular Therapies and Stem Cell Transplantation, who answered key questions from our audience. These...
Potential pitfall: In the early course of the disease, pancreatic cancer may not cause any signs or symptoms. However, sudden onset diabetes in groups of patients for whom this would be unexpected can be an early indicator. Helpful hint: NICE NG12 guidelines recommend...
Proton Pump Inhibitors (PPIs) are widely used to treat acid reflux and dyspepsia. NICE cautions that PPIs can mask or alter symptoms of stomach cancer, leading to later diagnoses. Potential Pitfall Patients on PPIs who have developed stomach cancer may increase their...
Whilst FIT can be a good indicator of bowel cancer, inflammatory bowel disease and sometimes precursors of cancer, some symptomatic patients can still have false negative results. With this in mind, how should you proceed? Potential Pitfall A normal result can miss...
Potential pitfall:
Faecal calprotectin testing is an incredibly sensitive investigation for detecting the presence of inflammation. It is raised in a wide variety of conditions including malignancy, inflammatory bowel disease and alcohol misuse. It is therefore not good at defining either the site or the cause of inflammation.
Helpful hint:
The NICE DG11 guidance recommends faecal calprotectin testing as an option to support clinicians with the differential diagnosis of inflammatory bowel disease (IBD), or irritable bowel syndrome (IBS), in adults with recent onset lower gastrointestinal symptoms for whom specialist assessment is being considered, if:
Cancer Keys are brought to you by GatewayC.
Download this Cancer Key here
Read the NICE NG12 guidance here
Access GatewayC’s Faecal Immunochemical Test (FIT) course here
Friday 23rd October 2020 Missed our free GatewayC webinar on Acute Leukaemia? Watch our recording here. In this webinar GatewayC met Dr Amit Patel, a Consultant in Cellular Therapies and Stem Cell Transplantation, who answered key questions from our audience. These...
Potential pitfall: In the early course of the disease, pancreatic cancer may not cause any signs or symptoms. However, sudden onset diabetes in groups of patients for whom this would be unexpected can be an early indicator. Helpful hint: NICE NG12 guidelines recommend...
Proton Pump Inhibitors (PPIs) are widely used to treat acid reflux and dyspepsia. NICE cautions that PPIs can mask or alter symptoms of stomach cancer, leading to later diagnoses. Potential Pitfall Patients on PPIs who have developed stomach cancer may increase their...
Whilst FIT can be a good indicator of bowel cancer, inflammatory bowel disease and sometimes precursors of cancer, some symptomatic patients can still have false negative results. With this in mind, how should you proceed? Potential Pitfall A normal result can miss...